Search

Search Constraints

You searched for: Author/Creator Galderisi, Silvana

Search Results

1. 17.2 NEGATIVE SYMPTOMS IN THE OPTiMISE COHORT: PREDICTION OF SHORT-TERM REMISSION STATE AND ASSOCIATION WITH PSYCHOSOCIAL FUNCTIONING. (9th April 2019)

2. 31.3 CLINICAL UTILITY OF MRI SCANNING IN FIRST EPISODE PSYCHOSIS. (1st April 2018)

3. A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa. Issue 1 (25th November 2021)

4. Abnormal bodily experiences detected by Abnormal Bodily Phenomena questionnaire are more frequent and severe in schizophrenia than in bipolar disorder with psychotic features. Issue 1 (2020)

7. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study. (October 2018)

8. Assessment of de novo copy-number variations in Italian patients with schizophrenia: Detection of putative mutations involving regulatory enhancer elements. (7th February 2019)

9. Avolition-Apathy and White Matter Connectivity in Schizophrenia: Reduced Fractional Anisotropy Between Amygdala and Insular Cortex. (January 2018)

10. Can IQ moderate the response to cognitive remediation in people with schizophrenia?. (January 2021)